Adverse events reporting system at Kaiser Permanente: Promoting collaboration for the protection of human subjects Arthur Durazo IRB Administrator Kaiser.

Slides:



Advertisements
Similar presentations
The Role of the IRB An Institutional Review Board (IRB) is a review committee established to help protect the rights and welfare of human research subjects.
Advertisements

Managing Compliance Related to Human Subjects Research Review Joseph Sherwin, Ph.D. Office of Regulatory Affairs University of Pennsylvania Fourth Annual.
UTHSC IRB Donna Hollaway, RN, CCRC 11/30/2011 Authority to Audit 45 CFR (e) An IRB shall conduct continuing review of research covered by this.
Reporting Unanticipated Problems Involving Risk to Subjects or Others and Adverse Events WFUHS Policy/Procedure Effective Date 6/1/07 Wendy Murray Monitoring.
TEXAS SOUTHERN UNIVERSITY INSTITUTIONAL ANIMAL CARE AND USE PROGRAM WORKSHOP OFFICE OF RESEARCH LINDA M. GARDINER, Ph.D. DIRECTOR RESEARCH ENHANCEMENT.
IRB Determinations 1. AAHRPP Site Visit Results Site visitors observed a real commitment to human subject protections Investigator and research staff.
1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
POST APPROVAL MONITORING AND EDUCATION PROGRAM Jane Lehmbeck 1, Sarah Blackman 1, Karen Davenport 2, Karen Parks 1 Office of the Vice President for Research.
1 © Huron Consulting Group Inc. All rights reserved. Huron is a management consulting firm and not a CPA firm, and does not provide attest services, audits,
Capturing and Reporting Adverse Events in Clinical Research
Pharmacists Responsibilities in Clinical Studies Mike R Sather, PhD Crystal L Harris, PharmD February 26, 2004.
John Naim, PhD Director Clinical Trials Research Unit
IRB-Investigator/ Research Coordinator Mtg. “CUMC’s New Progressive Policy For Adverse Event Reporting” April 13, 2004 George Gasparis Andrew Wit, Ph.D.
Human Research Protection Program CHR Post-Approval Event Reporting Wednesday, April 11, 2012 Beth Shields, MA, CIP, CCRA Quality Assurance Coordinator.
Columbia University IRB IRB 101 September 21, 2005 George Gasparis, Executive Director, CU IRB Asst. V.P. and Sr. Asst. Dean for Research Ethics.
CUMC IRB Investigator Meeting Human Subjects Research Non-Compliance September 15, 2005.
Human Research Protection Program Training: Post-Approval Event Reporting March 26, 2008 Lisa Voss, MPH, CIP Assistant Director, QIU Human Research Protection.
Unlocking the Mystery of General Information Reporting Research Compliance Administration Training Presentation Wednesday, June 6, 2007 Presenter:Heather.
Institutional Review Board (IRB) Human Subject Research Office (HSRO) University of Miami and Affiliated Institutions.
Who’s the Boss? Faculty Advisor or Principal Investigator Supervision versus Student Investigator or Study Coordinator Responsibilities Gwenn Snow, MS,
Adverse Events, Unanticipated Problems, Protocol Deviations & other Safety Information Which Form 4 to Use?
Response to FDA Audit 483 MX-4501N : Nine Category 483 Citations Meetings Minutes: Votes for, against, abstention and reason not recorded;
Adverse Events and Unanticipated Problems Presented by: Karen Jeans, PhD, CCRN, CIP COACH Program Analyst.
Using Technology to Strengthen Human Subject Protections Patricia Scannell Director, IRB Washington University School of Medicine.
Reporting Unanticipated Problems and Adverse Events: A Change in Policy Mary A. Banks RN, BS, BSN Director, BUMC IRB Wednesday, November 14, 2007.
Unanticipated Problems Potentially Involving Risks to Subjects or Others Research Protections Office Serving UVM and FAHC Updated April 2012.
Office of Research Oversight ORO Reporting Adverse Events in Research to ORO Paula Squire Waterman, MS, CIP Department of Veterans Affairs Office of Research.
RESCUE: ACRIN 4701 Protocol Development & Regulatory Compliance (PDRC) Josephine Schloesser, ACRIN Monitor Chris Steward, ACRIN QC Auditor.
Michelle Groy Johnson Quality Improvement Officer Research Integrity Office Tough Love: Understanding the Purpose and Processes of Quality Assurance.
Adverse Event/Unanticipated Problems Policy and Procedures November 2007.
University of Miami Office of Research Compliance Assessment Lynn E. Smith, JD, CIM, CIP Johanna Stamates, RN, BA, CCRC With assistance from Elizabeth.
Role of the Oncology Research Team Carmen B. Jacobs, BS, RN,OCN, CCRP U.T.M.D. Anderson Cancer Center Houston, Texas U.S.A.
The QA/QI Process Human Research Subjects Protection Human Investigation Committee Tracy Rightmer, JD, CIP Compliance Manager.
TERRENCE F. ACKERMAN, PH.D. PROFESSOR OF BIOETHICS CHAIR, UTHSC IRB.
Building Clinical Infrastructure and Expert Support Michael Steinberg, MD, FACR ULAAC Disparity Project Centinela/Freeman Health System.
UC DAVIS OFFICE OF RESEARCH Overview of Good Clinical Practices (GCP) Investigator and Study Team Responsibilities Miles McFann IRB Administration Training.
Belinda Seto, Ph.D. Acting Deputy Director for Extramural Research National Institutes of Health Human Subjects Research Enhancements Awards Renaissance.
The Research Subject Advocate (RSA). Pictured, left to right: Andrea Saltzman, RN; Enrico Cagliero, MD; Debi Dunkless.
Understanding Unanticipated Problems (UPs) Elizabeth Ness, RN, MS Director, Staff Development Office of the Clinical Director Center for Cancer Research,
The NCI Central IRB Initiative Third Annual Medical Research Summit Washington, D.C. March 2003.
Institutional Review Board Issues for Classroom Research Sharon McWhorter IRB Administrator, The University of Akron (With assistance from Phil Allen,
OBSERVED IN ORO REVIEWS COMPLIANCE ISSUES: OBSERVED IN ORO REVIEWS David A. Weber, Ph.D., FACNP Acting Chief Officer Office of Research.
Copyright FDA Inspections: Where Do Things Go Wrong? Diana Naser RN, MS, CCRP Executive Director Clinical Research Administration Clinical Research.
VHA Research Compliance Reporting Requirements ORD Accreditation Conference Call December 15, 2011.
Yadvindera (Bobby) Bains MD Director of Radiation Oncology, Laredo Medical Center Adjunct Associate Professor, Dept of Radiation Oncology, University of.
The NCI Central IRB Initiative Jacquelyn L. Goldberg, J.D. VA IRB Chair Training April 8, 2004.
Office of Research Oversight 1 Office of Research and Development Local Accountability Meeting January 2009.
Paul Kelly Facility Research Compliance Officer for the Ralph H. Johnson VA Medical Center.
Office of Human Research Protection Georgia Health Sciences University.
Conducting Research at Lincoln IRB/HRPP Policies, Procedures & Good Clinical Practices B Kanna MD, MPH, FACP Associate Program Director of Internal Medicine.
Emerging SACHRP Issues K. Lynn Cates, MD Assistant Chief Research & Development Officer Director, PRIDE Office of Research & Development Department of.
VA Central IRB K. Lynn Cates, MD Assistant Chief Research & Development Officer Office of Research & Development Department of Veterans Affairs September.
Marianne M. Elliott Office of Research Integrity and Ethics Bureau of Medicine and Surgery U. S Navy.
Office of Human Research (OHR) Quality Improvement Program Patrick Herbison Heather Krupinski.
Bussara Sukpanichnant, Human Subject Protection Office, USAMD-AFRIMS Unanticipated Problems 15 th FERCAP International Conference 24 Nov 15 Nagasaki, Japan.
Responsibilities of Sponsor, Investigator and Monitor
Cancer Clinical Trials Office Clinical Trials & Research Training Oct2014.
Supervisory Responsibilities of Clinical Investigators
Good Clinical Practice (GCP) and Monitoring Practices
Safety of the Subject Cena Jones-Bitterman, MPP, CIP, CCRP
Dartmouth Human Research Protection Program (HRPP) Data Safety Monitoring and Reporting requirements Brown Bag Series: Noon / First Tuesday of the Month.
Responsibilities of Sponsor, Investigator and Monitor
Adverse Event Reporting: Trials and Tribulations
Safety of the Subject Cena Jones-Bitterman, MPP, CIP, CCRP
AAHRPP Accreditation Welcome to the University of Georgia’s presentation for accreditation of the human research protection program (HRPP). This presentation.
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
HHS Reporting Requirements and Adverse Events
Event Reporting in Human Subjects Research
Research with Human Subjects
Risk Management NDS Forum June 23rd 2010.
Presentation transcript:

Adverse events reporting system at Kaiser Permanente: Promoting collaboration for the protection of human subjects Arthur Durazo IRB Administrator Kaiser Permanente Southern California

Learning Objectives Learning Objectives Discuss challenges faced by researchers and ethicists involved in creating a culture of safety.Discuss challenges faced by researchers and ethicists involved in creating a culture of safety.

Learning Objectives Learning Objectives Learn to develop standard operating procedures and shared systems for the proper reporting and auditing of adverse events to the federal agencies.Learn to develop standard operating procedures and shared systems for the proper reporting and auditing of adverse events to the federal agencies.

Learning Objectives Learning Objectives Recognize educational strategies for researchers to meet specific needs for patient safety and to protect the welfare, safety and health of research participants.Recognize educational strategies for researchers to meet specific needs for patient safety and to protect the welfare, safety and health of research participants.

Challenges Differences in terminology for adverse event (AE) versus an unanticipated problem (UP) among federal agenciesDifferences in terminology for adverse event (AE) versus an unanticipated problem (UP) among federal agencies

The KPSC Reporting Process The KPSC Reporting Process The KPSC IRB documents and reviews AEs and UPs occurring at KPSC sites in line with its existing standard operating procedures.The KPSC IRB documents and reviews AEs and UPs occurring at KPSC sites in line with its existing standard operating procedures.

The KPSC Reporting Process The KPSC Reporting Process KPSC researchers document the information required by DHHS/OHRP and FDA to submit reports of occurrences for IRB review to ensure compliance.KPSC researchers document the information required by DHHS/OHRP and FDA to submit reports of occurrences for IRB review to ensure compliance.

Case A laptop with human subjects’ Personal Health Information was stolen from the PI’s office. Included were names, dates of birth, medical record numbers and diagnosis. A laptop with human subjects’ Personal Health Information was stolen from the PI’s office. Included were names, dates of birth, medical record numbers and diagnosis.

Case Stolen laptop… Stolen laptop… Is this a UP and/or an AE? A protocol violation, deviation? Is this a UP and/or an AE? A protocol violation, deviation? How, when and to whom should this be reported? How, when and to whom should this be reported?

Self-Monitoring Activities In 2007, the KPSC IRB conducted a self-monitoring of its reporting processes to document UPs and AEs to: In 2007, the KPSC IRB conducted a self-monitoring of its reporting processes to document UPs and AEs to: Increase a “culture of conscience” with federal reporting guidelines, Increase a “culture of conscience” with federal reporting guidelines,

Self-Monitoring Activities … self-monitoring (continued): … self-monitoring (continued): Assess safety measures, Assess safety measures, Identify improvement needs, Identify improvement needs, Develop educational and mentoring opportunities. Develop educational and mentoring opportunities.

Methods Data was gathered retrospectively from existing reports of 243 AEs, SAEs and UPs submitted in by KPSC researchers. Data was gathered retrospectively from existing reports of 243 AEs, SAEs and UPs submitted in by KPSC researchers.

Results Findings showed: Findings showed: Researchers did not report UP and AEs within the time requirements according to existing KPSC standard operating procedures. Researchers did not report UP and AEs within the time requirements according to existing KPSC standard operating procedures.

Results Findings showed (continued): Findings showed (continued): Researchers were confused about to whom, how and when to report an UP versus an AE. Researchers were confused about to whom, how and when to report an UP versus an AE.

Results Findings showed (continued): Findings showed (continued): Existing procedures and forms to report UP and AE were not user- friendly and too stringent compared to the federal guidelines. Existing procedures and forms to report UP and AE were not user- friendly and too stringent compared to the federal guidelines.

Results Findings showed (continued): Findings showed (continued): Some UPs were not appropriately identified and reported to the institution and the federal agencies. Some UPs were not appropriately identified and reported to the institution and the federal agencies.

Conclusions Corrective action plans, educational and mentoring sessions advanced researchers understanding of the differences between AEs and UPs occurrences at KPSC sites. Corrective action plans, educational and mentoring sessions advanced researchers understanding of the differences between AEs and UPs occurrences at KPSC sites.

Conclusions Self-monitoring of AE s and UPs processes must be ongoing to comply with federal guidelines, improve safety measures and enhance reporting. Self-monitoring of AE s and UPs processes must be ongoing to comply with federal guidelines, improve safety measures and enhance reporting.

Conclusions The use of NCI’s* Central IRB increased monitoring and oversight and resulted in meeting compliance requirements by federal mandates. The use of NCI’s* Central IRB increased monitoring and oversight and resulted in meeting compliance requirements by federal mandates. *

Recommendations Continue self-monitoring efforts, including use of information systems such as iMedRIS to improve research participant safety. Continue self-monitoring efforts, including use of information systems such as iMedRIS to improve research participant safety.

Recommendations Increase mentoring opportunities to improve understanding and reporting of AEs and UPs. Increase mentoring opportunities to improve understanding and reporting of AEs and UPs.

Recommendations Continue to revise standard operating procedures to include new OHRP guidance recommendations towards a “culture of conscience.” Continue to revise standard operating procedures to include new OHRP guidance recommendations towards a “culture of conscience.”